3 research outputs found

    Phenotypic screening of cowpea (Vigna unguiculata (L.) Walp) genotypes for resistance to cowpea viral diseases

    Get PDF
    Viruses are a major constraint to cowpea production in sub-Saharan Africa. Host plant resistance is the most effective and reliable method of managing viral diseases. In order to identify the source of resistance or tolerance, 38 cowpea genotypes were screened for virus infection under field conditions during the 2016 wet and dry seasons. The experiment was laid out in a randomized complete block design with four replications in both seasons. Disease severity was assessed fortnightly based on disease symptom using 1-5 visual scale (1=symptomless, and 5= very severe symptom). The cowpea genotypes exhibited varying reactions to viral infections with mean disease incidence ranging from 17.7% in the fourth week to 29.2% in the eighth week for the wet season and from 34.4% to 53.1% for the fourth and eighth week, respectively in the dry season. Symptoms observed were leaf mosaic (86.7%), leaf mottling (86.7%), chlorotic spots (34.2%), vein clearing (28.9%), leaf curl (26.3%), necrotic lesions (15.8%) and stunting (10.5%). Symptom severity in the rainy season ranged from symptomless (severity score of 1) in IT10K-819-4 and IT07K-297-13 to moderate symptom (severity score of 2.9) in Apagbaala. However, in the dry season, the symptom severity score ranged from 1.11 (mild symptom) in Marfo Tuya to a score of 2.4 (moderate symptom) in IT07K-298-9, thus demonstrating a significant genotype x season interaction effect. Incidence and severity were significantly higher in the dry season than in the rainy season. There was a strong positive correlation between the disease incidence and disease severity as well as AUDPC and no correlation between the cowpea incidence and the seed yield and plant height in the wet season. There was a negative correlation between the incidence and plant height in the dry season. Six genotypes (IT07-210-1-1, IT07K-297-13, IT08K-193- 14, IT09-456, IT10K-817-3 and IT10K-819-4) exhibited mild symptoms and gave high yields in both seasons, thus demonstrating a stable G x E interaction effect. These disease resistant genotypes could be evaluated further before release to farmers.Keywords: Area Under Disease Progress Curve, Host resistance, Vigna unguiculata, Viral disease

    Overall and abdominal obesity and prostate cancer risk in a West African population: An analysis of the Ghana Prostate Study

    Get PDF
    Obesity has been associated with an increased risk of advanced prostate cancer. However, most studies have been conducted among North American and European populations. Prostate cancer mortality appears elevated in West Africa, yet risk factors for prostate cancer in this region are unknown. We thus examined the relationship between obesity and prostate cancer using a case-control study conducted in Accra, Ghana in 2004 to 2012. Cases and controls were drawn from a population-based sample of 1037 men screened for prostate cancer, yielding 73 cases and 964 controls. An additional 493 incident cases were recruited from the Korle-Bu Teaching Hospital. Anthropometric measurements were taken at enrollment. We used logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for associations between body mass index (BMI), waist circumference (WC), waist-hip ratio (WHR) and prostate cancer, adjusting for potential confounders. The mean BMI was 25.1 kg/m2 for cases and 24.3 kg/m2 for controls. After adjustment, men with BMI ≥ 30 kg/m2 had an increased risk of prostate cancer relative to men with BMI < 25 kg/m2 (OR 1.86, 95% CI 1.11-3.13). Elevated WC (OR 1.76, 95% CI 1.24-2.51) and WHR (OR 1.46, 95% CI 0.99-2.16) were also associated with prostate cancer. Associations were not modified by smoking status and were evident for low- and high-grade disease. These findings indicate that overall and abdominal obesity are positively associated with prostate cancer among men in Ghana, implicating obesity as a potentially modifiable risk factor for prostate cancer in this region

    Evaluation of skin absorption of drugs from topical and transdermal formulations

    Full text link
    corecore